165 related articles for article (PubMed ID: 8394726)
21. Pharmacology of migraine.
Raskin NH
Prog Drug Res; 1990; 34():209-30. PubMed ID: 2173018
[TBL] [Abstract][Full Text] [Related]
22. Distribution of [3H]-sumatriptan binding sites in human brain.
Connor HE
Cephalalgia; 1996 Aug; 16(5):287-8. PubMed ID: 8869759
[No Abstract] [Full Text] [Related]
23. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?
Shields KG; Goadsby PJ
Neurobiol Dis; 2006 Sep; 23(3):491-501. PubMed ID: 16875831
[TBL] [Abstract][Full Text] [Related]
24. Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic (5HT1 and 5HT2) receptors in dog brain and aorta.
Nagatomo T; Hokibara R; Tanaka Y; Nakamura T; Aono J; Tsuchihashi H
Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):3113-8. PubMed ID: 2907307
[No Abstract] [Full Text] [Related]
25. Abnormalities of serotonergic neurotransmission in animal models of SUDEP.
Feng HJ; Faingold CL
Epilepsy Behav; 2017 Jun; 71(Pt B):174-180. PubMed ID: 26272185
[TBL] [Abstract][Full Text] [Related]
26. [Current views on migraine and anti-migraine preparations].
Ignatov IuD; Skoromets AA; Amelin AV
Vestn Ross Akad Med Nauk; 2003; (10):13-9. PubMed ID: 14598505
[TBL] [Abstract][Full Text] [Related]
27. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
[TBL] [Abstract][Full Text] [Related]
28. On serotonin and migraine: a clinical and pharmacological review.
Ferrari MD; Saxena PR
Cephalalgia; 1993 Jun; 13(3):151-65. PubMed ID: 8395342
[TBL] [Abstract][Full Text] [Related]
29. Neurochemical alterations of serotonergic neuronal systems in depression.
Risch SC; Nemeroff CB
J Clin Psychiatry; 1992 Oct; 53 Suppl():3-7. PubMed ID: 1331029
[TBL] [Abstract][Full Text] [Related]
30. Single or repeated administrations of SCH 23390 fail to affect serotonergic neurotransmission.
Gandolfi O; Roncada P; Dall'Olio R
Neurosci Lett; 1988 Oct; 92(2):192-6. PubMed ID: 2460808
[TBL] [Abstract][Full Text] [Related]
31. [Prophylaxis of migraine].
Liaño H
Rev Neurol; 1995; 23 Suppl 2():S212-8. PubMed ID: 7497291
[No Abstract] [Full Text] [Related]
32. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
33. Comment on Esler et al. (2007) "Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor".
Hussain HM; Butt MU
Stress; 2008 Mar; 11(2):83-4. PubMed ID: 18311598
[No Abstract] [Full Text] [Related]
34. Selective serotonin reuptake inhibitors for migraine prophylaxis.
Landy S; McGinnis J; Curlin D; Laizure SC
Headache; 1999 Jan; 39(1):28-32. PubMed ID: 15613191
[TBL] [Abstract][Full Text] [Related]
35. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.
Abe S; Hori T; Suzuki T; Baba A; Shiraishi H; Yamamoto T
Neurochem Res; 1999 Mar; 24(3):359-63. PubMed ID: 10215509
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of 5-HT2 serotonin receptor: a possible mechanism of transformed migraine.
Srikiatkhachorn A; Govitrapong P; Limthavon C
Headache; 1994 Jan; 34(1):8-11. PubMed ID: 8132444
[TBL] [Abstract][Full Text] [Related]
37. Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs.
Murphy DL; Andrews AM; Wichems CH; Li Q; Tohda M; Greenberg B
J Clin Psychiatry; 1998; 59 Suppl 15():4-12. PubMed ID: 9786305
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitors pathway.
Sangkuhl K; Klein TE; Altman RB
Pharmacogenet Genomics; 2009 Nov; 19(11):907-9. PubMed ID: 19741567
[No Abstract] [Full Text] [Related]
39. 5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Deliganis AV; Peroutka SJ
Headache; 1991 Apr; 31(4):228-31. PubMed ID: 1646776
[TBL] [Abstract][Full Text] [Related]
40. [A new approach in the treatment of vascular headaches].
D'Attoma G; Nacci MG; D'Attoma A; Piccione M
Minerva Med; 1985 May; 76(21):1019-21. PubMed ID: 2860620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
